An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund.

Laura A TriggMaxwell S BarnishSamuel HaywardNaomi ShawLouise CrathorneBrad GrovesJohn SpoorsThomas StrongG J Melendez-TorresCaroline Farmer

Published in: PharmacoEconomics - open (2023)

The analysis indicated that data collection within the CDF is not sufficient to resolve all the uncertainties identified by the NICE committee, meaning that other approaches will be needed at re-appraisal to ensure that the NICE committee can reach a final decision on reimbursement.

Keyphrases

electronic health record
papillary thyroid
big data
squamous cell
data analysis
decision making
machine learning
palliative care
advanced cancer
childhood cancer
deep learning
drug induced